# OREGON HEALTH & SCIENCE UNIVERSITY: Identification of a new drug target, sarco-endoplasmic reticulum calcium-ATPase, for the treatment of Toxoplasma gondii infections and development of a selective inhibitor.

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | OREGON HEALTH & SCIENCE UNIVERSITY |
| Location | PORTLAND, OR |
| Project | Identification of a new drug target, sarco-endoplasmic reticulum calcium-ATPase, for the treatment of Toxoplasma gondii infections and development of a selective inhibitor. |
| Project number | 1R21AI196143-01A1 |
| Mechanism | R21 |
| Institute | National Institute of Allergy and Infectious Diseases |
| Award | $189,000 |
| Awarded | 2026-09-15 |
| Project period | 2026-09-15 to 2028-08-31 |
| UEI | NPSNT86JKN51 |

## Why this score
- Award of $189,000.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11453959). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.